CALAN SR
- Product NDC
- 0025-1891
- 11-digit product format
- 000251891
- Labeler code
- 0025
- Product ID
- 0025-1891_93e315dd-1373-4922-8117-994dc7c04833
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- verapamil hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- NDA019152
- Marketing category
- NDA
- Marketing start
- 1986-12-16
- Marketing end
- 2022-01-31
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 240 mg/1
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0025-1891-31 | 00025189131 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0025-1891-31) | 1986-12-16 | 2022-01-31 | No | No | Current |